---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-23-000463"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:24:39.740719+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics CFO Kenneth Fisher departs; Frances Scally named interim CFO

## Summary
- Kenneth R. Fisher ceased as CFO on September 26, 2023; may receive severance per employment agreement.
- Frances Scally, age 56, appointed interim CFO, principal financial officer and principal accounting officer.
- Scally is an employee of DLA LLC; services provided under a scope of work agreement on an hourly basis.
- Scott Levy of DLA also appointed as a special advisor to the CEO.

## SEC filing metadata
- accession: 0001013762-23-000463
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/ea186147-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-23-000463
- JSON: https://secwatch.observer/filing/0001013762-23-000463.json
- Plain text: https://secwatch.observer/filing/0001013762-23-000463.txt

## Key facts
- Executive change
  Kenneth R. Fisher departed as Chief Financial Officer at Bluejay Diagnostics, Inc..
  - Action: departed
  - Role: Chief Financial Officer
  source text: On September 26, 2023, Bluejay Diagnostics, Inc. (the “Company”) and Kenneth R. Fisher agreed that Mr. Fisher would depart the Company as an employee and cease serving as its Chief Financial Officer (“CFO”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm
- Executive change
  Scott Levy was appointed as special advisor to the CEO at Bluejay Diagnostics, Inc..
  - Action: appointed
  - Role: special advisor to the CEO
  source text: Under the these agreements, Scott Levy will complement Ms. Scally as a special advisor to the Company’s CEO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm
- Executive change
  Frances Scally was appointed as Chief Financial Officer at Bluejay Diagnostics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 26, 2023, the Board of Directors (the “Board”) of the Company appointed Frances Scally, age 56, as interim CFO of the Company and designated her as the Company’s principal financial officer and principal accounting officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.